Treatment of WHO Grade 2 and 3 Gliomas With Potentially Favorable Survival: Is Monotherapy Obsolete?

Previous central nervous system oncology scans in this publication have discussed management and molecular characterization of low-grade gliomas, (1) treatment strategies for high-grade gliomas in the elderly, (2) emerging treatment options for glioblastoma (GBM), (3) and molecular characterization of gliomas (4). Similar to trends observed in other oncologic diseases, grading gliomas by their molecular characteristics is emerging as a useful tool for identifying patients with potentially long-term survival after treatment of this disease.

http://bit.ly/2WJkIqA